Recruiting

Continuous Glucose Monitoring

Sponsor:

Children's Hospital Los Angeles

Code:

NCT06516640

Conditions

Type 2 Diabetes

Eligibility Criteria

Sex: All

Age: 8 - 21

Healthy Volunteers: Not accepted

Interventions

Continuous Glucose Monitoring Academy

Standard Education

Study Details

Brief summary:

The goal of this clinical trial is to evaluate the Impact of Continuous Glucose Monitoring Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 2 Diabetes (T2D):

  • The first aim is to determine how feasible it is to adapt the Continuous Glucose Monitoring Academy curriculum to teach youth with T2D glucose management strategies.
  • The second aim is to evaluate the effects of the Continuous Glucose Monitoring Academy metrics.
  • The third aim is to explore the relationships between these metrics with diabetes distress, diabetes family responsibilities, and process metrics.

Participants will join for a total of four weeks of education, followed by a six-month clinical review. They will have access to an online workbook and videos, and will participate in virtual sessions with a diabetes educator who will cover glucose management strategies in-depth. Participants will wear their preferred Continuous Glucose Monitoring system (Dexcom or FreeStyle Libre) provided via insurance and inserted at the baseline visit.

Conditions

Type 2 Diabetes

Study ID

NCT06516640

Start date

Jun 23, 2025

Status verified date

Jul, 2025

Completion date

Dec 30, 2026

Anticipated

Primary completion date

Sep 1, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 8 - 21

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Current age of 8-21 years;
2. T2D diagnosis;
3. Able to speak, read, and write English or Spanish

Exclusion Criteria:

a. Known history of medical adhesive allergies;

Study Design

Enrollment

60 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

placebo comparator: Control

Receives standard of care, regular education in the clinic.

experimental: Continuous Glucose Monitoring Academy

Receive an interactive workbook with problem-based learning scenarios and video links about Continuous Glucose Monitoring and glucose management strategies (CGM Academy Program). Participate in four in-depth online group sessions with diabetes care and education specialists complete questionnaires three times: at the time of study enrollment, week 4 and 6 months.

Interventions

Continuous Glucose Monitoring Academy

Educational materials as well as online sessions with diabetes educators.

Standard Education

Standard of care receives general education about diabetes.

Primary outcome measure

  • Mean change in Time in Range (TIR) from baseline to 6 months [ Time Frame: Baseline to 6 months ]

Central Contacts and Locations

Central contacts

Natalia Garban

3233611359ngarban@chla.usc.edu

Rebecca Barber

3233611359rbarber@chla.usc.edu

Locations

Children's Hospital Los Angeles

Recruiting

Los Angeles, California, United States, 90027

Contacts

Natalia Garban

ngarban@chla.usc.edu

Principal Investigator:

Rebecca Barber, PhD, RN

More Information

Sponsor

Children's Hospital Los Angeles

Last update posted

Feb 6, 2026

Last verified

Jul, 2025

Keywords

  • Continuous Glucose Monitoring
  • Glycemic Control
  • Diabetes Education
  • Type 2 Diabetes

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Children's Hospital Los Angeles on 2026-02-06.